Greenfield D S, Liebmann J M, Jee J, Ritch R
Department of Ophthalmology, The New York Eye and Ear Infirmary, NY 10003, USA.
Arch Ophthalmol. 1998 Apr;116(4):443-7. doi: 10.1001/archopht.116.4.443.
To determine the incidence of focal, late-onset, conjunctival bleb leaks after glaucoma filtering surgery.
Prospective, cross-sectional analysis.
Tertiary care outpatient referral center.
Consecutive patients who underwent glaucoma filtering surgery prior to June 1996 presenting for evaluation from September 2,1996, through November 15,1996. Five hundred twenty-five eyes of 525 consecutive patients were enrolled in the study.
Bleb height (elevated or flat), area (diffuse or localized), and wall thickness (thin, thick, or encapsulated) were classified. Each bleb was tested for focal leakage using a moistened fluorescein strip, cobalt blue illumination, and slit-lamp biomicroscopy. Diffuse transconjunctival aqueous flow did not qualify as a focal leak.
Seidel-positive aqueous leakage.
Bleb leakage occurred in 14 eyes following trabeculectomy (mitomycin C treatment, 10 eyes; 5-fluorouracil treatment, 3 eyes; no antifibrosis agent, 1 eye) and in 1 eye following combined cataract and glaucoma surgery with adjunctive mitomycin C therapy. Bleb leakage occurred more frequently in eyes that received mitomycin C (10 [3.7%] of 273 eyes) than 5-fluorouracil (3 [1.4%] of 213 eyes) or no antifibrosis agent (1 [2.6%] of 39 eyes), using Kaplan-Meier estimates (P=.008, log-rank test). Conjunctival blebs were significantly thinner after trabeculectomy with mitomycin C than with 5-fluorouracil (P=.001). Bleb wall thickness was greater following combined cataract and glaucoma surgery than following trabeculectomy alone (P=.008). Age (P=.84), sex (P=.68), race (P=.77), duration of mitomycin C exposure (P=.62), number of antiglaucoma medications (P=.16), and total 5-fluorouracil dose (P=.85) were not associated with late-onset leaks.
The risk of late-onset focal bleb leakage increases following trabeculectomy with mitomycin C therapy. Late leakage after combined cataract and glaucoma surgery is infrequent.
确定青光眼滤过术后局限性迟发性结膜滤泡渗漏的发生率。
前瞻性横断面分析。
三级医疗门诊转诊中心。
1996年6月前接受青光眼滤过手术的连续患者,于1996年9月2日至1996年11月15日前来评估。连续525例患者的525只眼纳入研究。
对滤泡的高度(隆起或扁平)、面积(弥漫性或局限性)和壁厚度(薄、厚或包膜状)进行分类。使用湿润的荧光素试纸、钴蓝光照明和裂隙灯生物显微镜检查每个滤泡是否存在局限性渗漏。弥漫性经结膜房水流动不视为局限性渗漏。
Seidel试验阳性的房水渗漏。
小梁切除术后14只眼发生滤泡渗漏(丝裂霉素C治疗,10只眼;5-氟尿嘧啶治疗,3只眼;未使用抗纤维化药物,1只眼),白内障与青光眼联合手术并辅助丝裂霉素C治疗后1只眼发生滤泡渗漏。使用Kaplan-Meier估计法(对数秩检验,P = 0.008),接受丝裂霉素C治疗的眼(273只眼中的10只[3.7%])比接受5-氟尿嘧啶治疗的眼(213只眼中的3只[1.4%])或未使用抗纤维化药物的眼(39只眼中的1只[2.6%])滤泡渗漏更频繁。小梁切除联合丝裂霉素C治疗后的结膜滤泡比联合5-氟尿嘧啶治疗后的明显更薄(P = 0.001)。白内障与青光眼联合手术后的滤泡壁厚度比单纯小梁切除术后更大(P = 0.008)。年龄(P = 0.84)、性别(P = 0.68)、种族(P = 0.77)、丝裂霉素C暴露时间(P = 0.62)、抗青光眼药物数量(P = 0.16)和5-氟尿嘧啶总剂量(P = 0.85)与迟发性渗漏无关。
小梁切除联合丝裂霉素C治疗后迟发性局限性滤泡渗漏风险增加。白内障与青光眼联合手术后的迟发性渗漏不常见。